DALLAS, Oct. 27, 2005 (PRIMEZONE) -- John Pentony, Publisher of StockGuru.com, announced today that the web site has released a new exclusive executive interview with Bill Radvack, President and CEO of Response Biomedical Corporation (OTCBB:RPBIF) (TSX-V:RBM). Mr. Radvack discusses recent developments at the company and gives shareholders a comprehensive update.
To listen to the StockGuru.com interview with Bill Radvack of Response Biomedical Corporation, please visit: http://www.stockguru.com/profiles/rpbif/interview.php
To view the StockGuru.com Profile for Response Biomedical Corporation, please visit: http://www.stockguru.com/profiles/rpbif/index.php
About StockGuru.com
StockGuru.com features daily alerts going out three times daily to members. To join our email alert list, please visit: http://www.stockguru.com/stocks.htm
To feature your publicly traded company in our alerts, or to discuss our complete services, please contact: John Pentony at (469) 252-3031, or email publisher@stockguru.com. Our services include our Morning, Midday, and After The Bell news releases. Additionally, we profile publicly traded companies on our web site, we do interviews with CEOs or other key executives on our web site, and we have our financial writers cover our companies.
Statements contained in this news release relating to future results, events and expectations, including statements relating to the proposed financing, are forward-looking statements within the meaning of Section 21E of the United States Securities Exchange Act of 1934. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievement of the company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such statements. Such factors include, among others, those described in the company's annual report on Form 20-F.
Disclosure: Pentony Enterprises LLC was compensated $10,000 for profile coverage. Pentony Enterprises LLC is not a registered investment advisers or broker/dealers. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.